Results: Eighty-seven patients who underwent TEVAR for type B aortic dissection were reviewed; 57 of 87 would have required zone 2 TEVAR. Indications for TEVAR were malperfusion (12), aneurysm (15), persistent pain (22), rupture (3), uncontrolled hypertension (5), and other (3). Mean followup was 19 months (range, 1-72 months). Only 17 patients (30%) met all the requirements for anatomic suitability (Fig). The reasons for failing anatomic suitability were covered stent graft length proximal to the branch portal (61%), aortic diameter at the proximal seal zone (11%), left subclavian diameter (16%), left subclavian length to its first branch (14%), and access vessel diameter (40%).
Objective: Our institution has noted a continual rise in the incidence of late graft failure by type III endoleak (T3EL) with early-generation AFX (Endologix, Irvine, Calif) endografts. We also noted repeated T3ELs in these patients treated with bridging AFX grafts. Previous authors noted a much lower incidence of T3EL (0%-5%) but high aneurysm-related mortality (18%) when repairing T3ELs with bridging grafts. Failure rates may be due to significant aortic remodeling in this population.
Methods: We sought to further characterize this population by instituting a targeted campaign to improve follow-up of 107 patients who had endovascular aneurysm repair with early-generation AFX devices. We then analyzed clinical and radiographic data including index procedures, anatomic data, and clinical follow-up between 2009 and 2018.
Results: Of 107 patients with early-generation AFX grafts, 26 developed T3EL (24.3%). Computed tomography scan follow-up was obtained in 63.1%. Complete endograft relining occurred in 22 patients; indications were type IIIA (4) and type IIIB (18) endoleaks. Concomitant leaks included type IA endoleak (one), type IB endoleak (two), and migration (one). Complete endograft relining was performed with 100% technical success. After relining, all patients had resolution of T3EL and all associated endoleaks, on both angiography and follow-up computed tomography scan to date. Endografts used include Excluder (two; W. L. Gore & Associates, Flagstaff, Ariz), Zenith (one; Cook Medical, Bloomington, Ind), and Ovation iX (TriVascular, Santa Rosa, Calif) for our most recent 19 patients (86%). Average time to reline was 45.2 months (1.6-70.4 months), and average follow-up after relining was 13 months (1.0-41.8 months). Drastic changes were noted after relining in aortic diameter (À8 mm [À1.0 mm to À38.0 mm]) and renal to aortic bifurcation lengths (À12 mm [À1.0 mm to À24.0 mm]).
Conclusions: We have shown that after initiation of a targeted followup campaign, the incidence of early Endologix AFX graft failure from T3EL is significantly higher than previously reported (24.3%). Changes to device design have improved on this issue. These patients have significant aortic remodeling potentially contributing to their failure. Adopting a complete endograft relining approach appears to take advantage of alternative locations of fixation and seal and completely excludes the previously placed endograft, achieving durable midterm outcomes while maintaining a minimally invasive approach. Objective: A transmetatarsal amputation (TMA) allows patients with forefoot wounds to maintain ambulatory function and preserves a sensate heel and ankle. However, healing after TMA is often compromised in older patients by peripheral artery disease (PAD). The aim of this study was to investigate the effect of lower extremity revascularization (LER) on TMA healing and prevention of major amputation.
Methods: A retrospective review was conducted of all patients who had a TMA at three centers of a multicenter vascular practice from January 1, 2008, to December 31, 2016. In January 2012, a multidisciplinary limb salvage team consisting of vascular surgeons and podiatrists was established. Data on demographics, procedural details, and outcomes were collected.
Results: A total of 124 patients had 134 TMAs with a median follow-up of 1221 days (interquartile range [IQR] , 730-1757 days). The mean age was 60.9 6 11.5 years; 81% were men, 87% had diabetes, 56% had PAD, and 31% had coronary artery disease (CAD). Of 134 TMAs, 68% (91) healed, 10% (14) had recurrent wounds, and 22% (29) Conclusions: TMA is a successful and durable procedure for patients with advanced foot wounds. Whereas TMA healing is time and labor intensive, aggressive use of LER can achieve TMA healing and avoid major amputation in older patients with PAD.
